PPARA and Parkinson disease: In summary, the present study identified valuable serum metabolic alterations that distinguish PD patients from HCs and PD-RBD patients from PD-nRBD patients, implicating dysregulated pathways (e.g., CCM and PPAR signaling) in PD pathogenesis.